Have you ever taken more insulin to correct stubborn hyperglycemia, only to unexpectedly plunge into hypoglycemia two hours later? If so, it might be that...

Written in April 2024 – Last updated in April 2025 It has now been exactly one year since Health Canada approved the first tubeless “artificial...

2024 ended with the much-anticipated announcement for Canadian users of the Tandem t:slim X2 pump: The Dexcom G7 Continuous Glucose Monitor (CGM) is finally compatible...

Novo Nordisk announced, in early October 2024, that it would soon cease the production and marketing of some products—including several types of insulin—from its diabetes...

Last March, Canada became the very first country to authorize a once-weekly “super slow” basal insulin. Novo Nordisk’s icodec insulin, which will soon be available...

Hyperglycemia (blood sugar > 10 mmol/L)—just like hypoglycemia (blood sugar < 4.0 mmol/L)—is one of the many challenges faced by people with type 1 diabetes (T1D). There are...

There has been a shortage of Ozempic (semaglutide) in pharmacies for the past few months, as manufacturer Novo Nordisk has been struggling to meet the...

Novo Nordisk Canada/Paladin Labs has recently announced the end of production of its GlucaGen HypoKit, following in the steps of Eli Lilly, who also recently...

The Eli Lilly Company recently announced that it will stop producing and selling its emergency glucagon injection kit used to treat severe hypoglycemic episodes. In...

Reference insulin products are increasingly being replaced with biosimilar types of insulin. Until recently, three biosimilar insulin products were available in Canada: Admelog, biosimilar version...

Since June 14, 2022, Admelog insulin (Humalog biosimilar) is out of stock in 10 ml vial. This situation could continue until September 2022!!! IMPORTANT: The...

People with type 1 diabetes (T1D) who use a continuous glucose monitoring (CGM) system (e.g., Dexcom, FreeStyle Libre) and/or an insulin pump (e.g., Medtronic, Omnipod)...

Prolonged hyperglycemia, or high blood sugar levels over several years in people with diabetes, can affect different organs, such as the heart or blood vessels....

UPDATE February 2th, 2022: BAQSIMI ™ is now cover by the RAMQ for people who use insulin. At the end of September 2019, Health Canada...

One type of biosimilar insulin was approved by Health Canada for the first time in 2019, and many other types have been made available ever...

Would you like to get more insights from your Freestyle Libre, Dexcom or insulin pump data reports? Adults who are signed up to the BETTER...

Ever since insulin was first used in Toronto 100 years ago, the daily lives of people living with type 1 diabetes (T1D) have been transformed...

Reference Gradel, A. K., Porsgaard, T., Lykkesfeldt, J., Seested, T., Gram-Nielsen, S., Kristensen, N. R., &amp; Refsgaard, H. H. (2018). Factors Affecting the Absorption of...

Find out more  References Carter, A. W., Heinemann, L. (2017). Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in...

The BETTER registry aims to improve the access of people with type 1 diabetes to treatment and technologies in Quebec. If you or your child...

Research is still needed to precisely understand how summer and temperature changes affect blood sugar levels and its management, here is what is known.  The...

In 2018, several new technologies for diabetes treatment appeared on the Canadian market. The BETTER team, which is interested in the role of new technologies...